RTI-Supported Clinical Trial Finds Single-Dose Antibiotic Significantly Reduced The Risk Of Maternal Sepsis Or Death
February 10, 2023
February 10, 2023
RESEARCH TRIANGLE PARK, North Carolina, Feb. 10 (TNSjou) -- RTI International issued the following news release on Feb. 9, 2023:
RTI International, a nonprofit research institute, took part in a large multinational clinical trial that found a single oral dose of the antibiotic azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally, by one-third.
Sepsis is a severe infection in the body that can lead to tissue damage, organ fail . . .
RTI International, a nonprofit research institute, took part in a large multinational clinical trial that found a single oral dose of the antibiotic azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally, by one-third.
Sepsis is a severe infection in the body that can lead to tissue damage, organ fail . . .